Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

UCB and ImClone terminate CDP-791 agreement

Feb. 9, 2007

Pro-Pharmaceuticals commences NDA filing for Davanat

Feb. 8, 2007

European label extension sought for Evoltra for elderly patients with AML

Feb. 8, 2007

Romidepsin studied with bortezomib for relapsed/refractory multiple myeloma

Feb. 8, 2007

Genta to appeal Genasense non-approvable letter in CLL

Feb. 8, 2007

European orphan drug designation for Fodosine in CTCL

Feb. 8, 2007

Elacyt to be studied for metastatic colorectal cancer

Feb. 8, 2007

Glufosfamide studied in new phase II trial for recurrent, sensitive SCLC

Feb. 8, 2007

Favorable data on the gemcitabine/Myocet combination from a phase II trial

Feb. 8, 2007

Clinical data on vinflunine in metastatic breast cancer presented

Feb. 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...